Vontier (VNT) Competitors $32.18 +0.38 (+1.18%) Closing price 05/1/2025 03:59 PM EasternExtended Trading$32.22 +0.03 (+0.11%) As of 04:42 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock VNT vs. TER, RVTY, AVTR, BIO.B, NVMI, MIR, ST, CAMT, TXG, and TRNSShould you be buying Vontier stock or one of its competitors? The main competitors of Vontier include Teradyne (TER), Revvity (RVTY), Avantor (AVTR), Bio-Rad Laboratories (BIO.B), Nova (NVMI), Mirion Technologies (MIR), Sensata Technologies (ST), Camtek (CAMT), 10x Genomics (TXG), and Transcat (TRNS). These companies are all part of the "measuring and control equipment" industry. Vontier vs. Teradyne Revvity Avantor Bio-Rad Laboratories Nova Mirion Technologies Sensata Technologies Camtek 10x Genomics Transcat Vontier (NYSE:VNT) and Teradyne (NASDAQ:TER) are both business services companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, valuation, community ranking, analyst recommendations, media sentiment, profitability, earnings, dividends and risk. Which has more risk & volatility, VNT or TER? Vontier has a beta of 1.28, suggesting that its stock price is 28% more volatile than the S&P 500. Comparatively, Teradyne has a beta of 1.65, suggesting that its stock price is 65% more volatile than the S&P 500. Do insiders & institutionals hold more shares of VNT or TER? 95.8% of Vontier shares are held by institutional investors. Comparatively, 99.8% of Teradyne shares are held by institutional investors. 1.0% of Vontier shares are held by insiders. Comparatively, 0.2% of Teradyne shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Does the MarketBeat Community prefer VNT or TER? Teradyne received 41 more outperform votes than Vontier when rated by MarketBeat users. However, 52.87% of users gave Vontier an outperform vote while only 48.07% of users gave Teradyne an outperform vote. CompanyUnderperformOutperformVontierOutperform Votes4652.87% Underperform Votes4147.13% TeradyneOutperform Votes8748.07% Underperform Votes9451.93% Which has higher earnings and valuation, VNT or TER? Teradyne has lower revenue, but higher earnings than Vontier. Vontier is trading at a lower price-to-earnings ratio than Teradyne, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVontier$2.98B1.60$422.20M$2.7511.70Teradyne$2.82B4.21$542.37M$3.5420.84 Does the media favor VNT or TER? In the previous week, Teradyne had 22 more articles in the media than Vontier. MarketBeat recorded 45 mentions for Teradyne and 23 mentions for Vontier. Vontier's average media sentiment score of 1.35 beat Teradyne's score of 0.89 indicating that Vontier is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Vontier 15 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Teradyne 22 Very Positive mention(s) 1 Positive mention(s) 12 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Positive Is VNT or TER a better dividend stock? Vontier pays an annual dividend of $0.10 per share and has a dividend yield of 0.3%. Teradyne pays an annual dividend of $0.48 per share and has a dividend yield of 0.7%. Vontier pays out 3.6% of its earnings in the form of a dividend. Teradyne pays out 13.6% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Do analysts prefer VNT or TER? Vontier presently has a consensus target price of $43.17, indicating a potential upside of 34.12%. Teradyne has a consensus target price of $117.56, indicating a potential upside of 59.34%. Given Teradyne's higher probable upside, analysts clearly believe Teradyne is more favorable than Vontier.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Vontier 0 Sell rating(s) 2 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.71Teradyne 2 Sell rating(s) 3 Hold rating(s) 11 Buy rating(s) 1 Strong Buy rating(s) 2.65 Is VNT or TER more profitable? Teradyne has a net margin of 19.23% compared to Vontier's net margin of 14.17%. Vontier's return on equity of 43.22% beat Teradyne's return on equity.Company Net Margins Return on Equity Return on Assets Vontier14.17% 43.22% 10.38% Teradyne 19.23%19.08%14.47% SummaryTeradyne beats Vontier on 14 of the 21 factors compared between the two stocks. Get Vontier News Delivered to You Automatically Sign up to receive the latest news and ratings for VNT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VNT vs. The Competition Export to ExcelMetricVontierFluid meters & counting devices IndustryBusiness SectorNYSE ExchangeMarket Cap$4.77B$5.69B$22.15B$18.96BDividend Yield0.32%0.48%2.58%4.01%P/E Ratio11.7032.4030.6832.87Price / Sales1.604.68171.4928.03Price / Cash10.1425.4931.5117.52Price / Book4.517.715.024.47Net Income$422.20M$273.57M$194.53M$1.02B7 Day Performance2.79%3.30%0.23%0.59%1 Month Performance-4.41%5.11%2.48%-3.54%1 Year Performance-20.24%-0.16%11.15%3.80% Vontier Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VNTVontier4.265 of 5 stars$32.19+1.2%$43.17+34.1%-20.8%$4.77B$2.98B11.708,100Earnings ReportNews CoveragePositive NewsTERTeradyne4.9482 of 5 stars$76.83-0.4%$118.94+54.8%-35.1%$12.36B$2.82B23.076,500Earnings ReportAnalyst ForecastBuyback AnnouncementOptions VolumeAnalyst RevisionRVTYRevvity3.7296 of 5 stars$95.00+0.8%$130.50+37.4%-9.4%$11.41B$2.76B42.9916,700Earnings ReportAnalyst ForecastAnalyst RevisionNews CoverageHigh Trading VolumeAVTRAvantor4.6524 of 5 stars$12.49-3.4%$19.32+54.7%-46.8%$8.51B$6.78B12.0114,500Earnings ReportAnalyst DowngradeHigh Trading VolumeBIO.BBio-Rad LaboratoriesN/A$234.41flatN/A-16.3%$6.57B$2.57B-3.608,200Earnings ReportNVMINova2.9977 of 5 stars$196.04-0.3%$264.60+35.0%+16.9%$5.74B$672.40M34.151,180Upcoming EarningsNews CoveragePositive NewsMIRMirion Technologies1.7227 of 5 stars$15.40+0.5%$18.75+21.8%+54.8%$3.58B$860.80M-81.052,870Earnings ReportNews CoveragePositive NewsSTSensata Technologies4.9085 of 5 stars$21.36+0.3%$33.33+56.1%-45.2%$3.19B$3.93B25.4320,800Upcoming EarningsCAMTCamtek3.6851 of 5 stars$66.37-0.3%$103.13+55.4%-16.5%$3.03B$429.23M27.43400Upcoming EarningsTXG10x Genomics4.664 of 5 stars$8.48+2.2%$19.79+133.3%-69.9%$1.04B$610.79M-5.581,240Upcoming EarningsNews CoveragePositive NewsTRNSTranscat2.2423 of 5 stars$80.98-4.9%$111.50+37.7%-25.9%$753.84M$272.20M43.77920Positive News Related Companies and Tools Related Companies Teradyne Competitors Revvity Competitors Avantor Competitors Bio-Rad Laboratories Competitors Nova Competitors Mirion Technologies Competitors Sensata Technologies Competitors Camtek Competitors 10x Genomics Competitors Transcat Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:VNT) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredMassive dollar overhaul underway in D.C.?Trump's plan to save the U.S. Dollar The U.S. Dollar is crashing, and our reserve currency status is now in...Stansberry Research | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vontier Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vontier With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.